Objective: There are no guidelines to select isolated heart transplantation or simultaneous heart and kidney transplantation in patients with renal dysfunction. We sought to assess the effect of simultaneous kidney transplantation on heart-transplantation outcome in patients with renal dysfunction. Methods: Retrospective case review. Results: Between 1993 and 2006, 45 patients with preoperative serum creatinine !2 mg dl À1 underwent heart transplantation, including 32 isolated heart transplantation and 13 simultaneous heart and kidney transplantation. The survival of 83.3 AE 10.8% at 30 days, 58.3 AE 14.2% at 1 year and 50.0 AE 14.4% at 3 years in simultaneous heart and kidney transplantation did not differ from the survival of 81.8 AE 6.7% at 30 days, 66.7 AE 8.2% at 1 year and 45.1 AE 9.3% at 3 years in isolated heart transplantation. The dialysis-free and patient survival of 66.7 AE 13.6% at 30 days, 58.3 AE 14.2% at 1 year and 50.0 AE 14.4% at 3 years in simultaneous heart and kidney transplantation also did not differ from the rate of 81.8 AE 6.7% at 30 days, 66.7 AE 8.2% at 1 year and 31.4 AE 8.9% at 3 years in isolated heart transplantation. Conclusions: Simultaneous kidney transplantation is an effective therapy for patients depending on dialysis pretransplant, reducing postoperative risk of mortality in these very sick patients to the level of patients with less severe renal disease not requiring dialysis before transplant. #
Introduction
In heart transplantation, preoperative renal dysfunction is one of the major risk factors for mortality [1] . Severe renal dysfunction is generally considered to be a relative contraindication to heart transplantation [2] . However, patients with severe renal dysfunction are transplanted. In select patients with co-existing end-stage heart and renal failure, simultaneous heart and kidney transplantation proved to have satisfactory results [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Simultaneous heart and kidney transplantation become an accepted therapeutic option for patients with end-stage heart failure associated with severe renal dysfunction. However, there are no guidelines at this moment to select isolated heart transplantation or simultaneous heart and kidney transplantation in patients with preoperative renal dysfunction. Here, we sought to assess the effect of simultaneous kidney transplantation on clinical outcome of heart transplantation in recipients with preoperative renal dysfunction.
Patients and methods

Patients
A total of 276 consecutive patients underwent heart transplantation from June 1993 through October 2006 at the National Taiwan University Hospital. Renal dysfunction was defined as a serum creatinine !2 mg dl À1 at transplant. This study included 45 patients (16%) having preoperative renal dysfunction. Patient characteristics were summarised in Table 1 . Of the 45 patients with preoperative serum creatinine !2 mg dl À1 , 32 patients (71%) underwent isolated heart transplantation and 13 underwent simultaneous heart and kidney transplantation.
Thirty-eight patients were male (84%). The median age at transplant was 52.8 years (range, 11.1-68.8). End-stage heart failure was secondary to dilated cardiomyopathy in 17 patients (38%), ischaemic cardiomyopathy in 17 (38%), cardiac allograft vasculopathy in four (9%), valvular heart disease in three (7%), congenital heart disease in two, and non-diagnostic cardiac allograft failure and acute myocarditis in one each. In 20 patients (44%), a previous cardiac surgery was recorded and included coronary artery bypass grafting in nine patients, previous heart transplantation in five, previous valvular replacement in four, Rastelli operation in one and implantation of centrifugal left ventricular assist device in one.
Thirty-two patients (71%) were in United Network for Organ Sharing (UNOS) status I at transplant and 13 patients in UNOS status II. Fourteen patients (31%) had endotracheal intubation and mechanical ventilation before transplantation. Mechanical circulatory support before transplantation was required in nine patients, and it included intra-aortic balloon pump in one patient, extracorporeal membrane oxygenation in two and combined use in six.
These patients, affected by end-stage heart failure, had severe renal dysfunction at the time of heart transplantation. Majority of the patients underwent isolated heart transplantation. Some of them underwent simultaneous heart and kidney transplantation while both heart and renal allografts were available from the same donor. Patients requiring long-term (>6 months) dialysis were not considered for isolated heart transplantation. Donors were matched for each recipient on the basis of donor and recipient ABO blood group identity and donor/recipient body weight ratio !0.8.
Data on age, sex, diagnosis of heart disease, cardiac allograft ischaemic time, cardiopulmonary bypass time, renal and liver function tests before transplantation and clinical outcomes were recorded.
Heart transplantation
All of the procedures of heart transplantation were performed through a median sternotomy. Heart and kidney harvesting, preservation and grafting were performed according to the routine technique. Orthotopic heart transplantation was performed first in all cases. After haemodynamic stability and haemostasis were achieved, the chest was closed, and kidney transplantation was then performed without delay in standard fashion [14] .
Postoperative management in intensive care unit was the same as that in routine patients receiving isolated heart transplantation. Blood components were given whenever needed and no aprotinin was used in our patients.
Immunosuppression
All patients received triple-drug immunosuppressive therapy according to our heart-transplantation protocol, as previously described [14] [15] [16] . We used rabbit anti-thymocyte globulins for induction therapy. Azathioprine (4 mg kg À1 ) was given 1 h before the operation. Solumedrol (1000 mg) was infused while releasing the aortic cross-clamp. Cyclosporine was started orally within 5 days after transplantation or after the recovery of renal function. Cyclosporine dose was by the first month after transplantation. Tacrolimus and mycophenolate mofetil were used for recurrent cardiac allograft rejection or severe adverse reactions to cyclosporine and azathioprine. Since 2004, we started to use mycophenolate mofetil for primary immunosuppression instead of azathioprine. All patients were followed monthly at special cardiac transplantation clinic. Standard chest roentgenogram, blood tests, electrocardiogram and physical examinations were routinely performed at regular intervals.
Endomyocardial biopsy was performed weekly in the first month, biweekly in the second month, monthly in the 6 months and yearly 6 months after transplantation. For those patients surviving for more than 6 months after transplantation, coronary angiography was performed annually for surveillance of cardiac allograft vasculopathy. The kidney allograft was followed with serial determination of serum blood urea nitrogen and serum creatinine. Needle biopsy of the kidney allograft was undertaken only if there was an elevation in serum creatinine over baseline that did not respond to standard treatment.
Statistical analysis
The results are expressed as median with a range or mean with standard deviation and frequencies for the categorical variables. Univariate associations between potential preoperative and intra-operative predictors and mortality were assessed with chi-square test, Fisher's exact test and MannWhitney test, as appropriate. Then stepwise logistic regression was performed for risk factors of 1-year mortality and included all potential predictors associated with a p < 0.1 from the univariate analysis. Results for the multivariate models are reported as odds ratios with associated 95% confidence intervals. Dialysis-free and patient survival was defined as patients who survived and free of dialysis. Both patient and graft survival curve and dialysis-free and patient survival curve were plotted by the Kaplan-Meier method. Survival was compared by log-rank test. p 0.05 was considered statistically significant. The dialysis-free and survival of all patients with preoperative renal dysfunction was compared with a control patients with preoperative serum creatinine <2 mg dl À1 . This control cohort included 231 patients with 188 male (81%). End-stage heart failure was secondary to dilated cardiomyopathy in 130 patients (56%), ischaemic cardiomyopathy in 61 (26%), and others.
Results
Patients undergoing simultaneous heart and kidney transplantation had higher serum creatinine and dialysis at transplant ( Table 1) . As shown in Table 1 , 38 donors (84%) were male with median age of 35 years (range: 16-66 years). The median duration of cardiac allograft ischaemic time was 147 min (range: 86-311 min). The median duration of cardiopulmonary bypass time was 167 min (range: 63-436 min).
Hospital outcome
Of the 13 patients undergoing simultaneous heart and kidney transplantation, two died within 30 days and five died in-hospital. The causes of hospital mortality were bacterial sepsis in four patients and surgical bleeding in one. One patient died after 1 day of surgical bleeding. Other major postoperative complications included severe right ventricular failure requiring extracorporeal membrane oxygenation support in two patients, ischaemic stroke in one, poststernotomy mediastinitis in one and de novo diabetes mellitus in one. Bloodstream infection occurred in five patients, and it led to four hospital mortalities after 27 days, 33 days, 2 months and 10 months.
Of the 32 patients undergoing isolated heart transplantation, six died within 30 days and eight died within hospitalisation. The causes of hospital mortality were postcardiotomy shock and sepsis in three patients, surgical bleeding in two, ischaemic bowel disease in one, poststernotomy mediastinitis in one and sepsis in one. Two patients died after 3 days of surgical bleeding. Postcardiotomy shock requiring extracorporeal membrane oxygenation support occurred in four patients, and it led to three hospital mortalities after 6 days, 12 days and 46 days. Poststernotomy mediastinitis occurred in three patients, and it led to one hospital mortality after 4 months. Other major postoperative complications included reopen for bleeding in four patients, acute renal failure requiring dialysis therapy in four, urinary tract infection in one and ischaemic stroke in one. Bloodstream infection occurred in four patients, and it led to two hospital mortalities.
In total, the 30-day mortality rate and in-hospital mortality rate were 18% and 29%, respectively: 15% and 38% in those patients undergoing simultaneous heart and kidney transplantation and 19% and 25% in those patients undergoing isolated heart transplantation.
Patient and graft survival
Follow-up was complete in all patients. The median duration of follow-up was 23.5 months (range, 1 day to 147 months). As shown in Fig. 1 , the mortality rates of simultaneous heart and kidney transplantation led to an overall Kaplan-Meier survival of 83.3 AE 10.8% at 30 days, 58.3 AE 14.2% at 1 year, 50.0 AE 14.4% at 3 years and 50.0 AE 14.4% at 5 years. The mortality rates of isolated heart transplantation in patients with preoperative serum creatinine !2 mg dl À1 led to an overall Kaplan-Meier survival of 81.8 AE 6.7% at 30 days, 66.7 AE 8.2% at 1 year, 45.1 AE 9.3% at 3 years and 30.1 AE 9.4% at 5 years. There was no difference between the two groups. These results did not match with our survival of isolated heart transplantation in patients with preoperative serum creatinine <2 mg dl À1 , that is, 94.4 AE 1.5% at 30 days, 85.3 AE 2.3% at 1 year, 74.6 AE 3.0% at 3 years and 67.3 AE 3.4% at 5 years (Fig. 1). 
Risk factor analysis
As shown in Table 2 , more patients with mortality after 1 year had prolonged duration of cardiopulmonary bypass and postoperative dialysis. Multivariate logistic regression iden-tified two independent risk factors for mortality after 1 year: prolonged duration of cardiopulmonary bypass in minutes (odds ratio, 1.01; 95% confidence interval, 1.00-1.03; p = 0.02) and postoperative dialysis (odds ratio, 15.7; 95% confidence interval, 1.89-130.9; p = 0.01). Simultaneous kidney transplantation had no effect on mortality after 1 year.
Renal outcome
Of the 13 patients undergoing simultaneous heart and kidney transplantation, immediate diuresis from the transplant kidney started in 10 patients. Renal function gradually normalized, with serum creatinine ranging from 0.5 to 3.0 mg dl À1 at 1 month after kidney transplantation. Two patients did not recover autonomous renal function immediately after kidney transplantation, and underwent regular dialysis treatment after transplantation. Postoperative dialysis therapy was required in 3 of 12 patients (25%) who survived beyond 7 days. Other major renal allograft complications have been acute cellular rejection in two patients and crescentic glomerulonephritis in one. At outpatient follow-up, none of the eight patients who survived after discharge required dialysis therapy. Till date, five surviving patients have functioning kidney allografts with a follow-up duration ranging from 20 to 146 months; the serum creatinine in the surviving patients ranged from 1.1 to 2.2 mg dl À1 at the last outpatient visit. In isolated heart transplantation, postoperative dialysis was required in 9 of 30 patients (30%) who survived beyond 7 days. At outpatient follow-up, 7 of 24 patients who survived after discharge required dialysis therapy. Till date, eight surviving patients have functioning kidney with a follow-up duration ranging from 17 to 124 months; the serum creatinine in the surviving patients ranged from 0.9 to 3.0 mg dl À1 at the last outpatient visit.
The dialysis rates of simultaneous heart and kidney transplantation led to an overall Kaplan-Meier dialysis-free and patient survival of 66.7 AE 13.6% at 30 days, 58.3 AE 14.2% at 1 year, 50.0 AE 14.4% at 3 years and 50.0 AE 14.4% at 5 years. The dialysis rates of isolated heart transplantation in patients with preoperative serum creatinine !2 mg dl À1 led to an overall Kaplan-Meier dialysis-free and patient survival of 81.8 AE 6.7% at 30 days, 66.7 AE 8.2% at 1 year, 31.4 AE 8.9% at 3 years and 17.9 AE 7.8% at 5 years. There was no difference between the two groups. These results did not match with our dialysis-free and patient survival of isolated heart transplantation in patients with preoperative serum creatinine <2 mg dl À1 , that is, 94.4 AE 1.5% at 30 days, 85.3 AE 2.3% at 1 year, 74.6 AE 3.0% at 3 years and 66.1 AE 3.5% at 5 years (Fig. 2 ).
Discussion
Previous studies have demonstrated that preoperative renal dysfunction and postoperative renal dysfunction are associated with mortality of heart transplantation [17] [18] [19] [20] [21] . Preoperative serum creatinine >1.5-2.0 mg dl À1 or creatinine clearance <40-50 ml min À1 predicts the development of postoperative renal failure and mortality in patients undergoing heart transplantation [19] [20] [21] . In re-transplantation, patients with serum creatinine !2.0 mg dl À1 had a high probability of requiring postoperative dialysis and also of mortality [22] . In this current series, patients with preoperative serum creatinine !2 mg dl À1 had a higher 30-day mortality compared to patients with serum creatinine <2 mg dl À1 . The mortality rate of 18% in our patients with preoperative renal dysfunction is similar to that reported in the previous studies [18] [19] [20] [21] . However, our patients undergoing isolated heart transplantation had a comparable survival rate to our patients undergoing simultaneous heart and kidney transplantation. Postoperative dialysis and prolonged cardiopulmonary bypass duration were the most significant predictors of mortality after 1 year.
Heart and kidney transplantation
An abnormal renal function before surgery portends a worse prognosis in adult recipients after heart transplantation [17] [18] [19] [20] [21] . However, when serum creatinine was evaluated as a continuous variable, no specific level was identified beyond which the risk of heart transplantation was unacceptable [2] . Nevertheless, previous reports in patients with renal dysfunction have suggested a serum creatinine >2 mg dl À1 [22] or glomerular filtration rate <30 ml min
À1
[12] as an indication for simultaneous heart and kidney transplantation. The number of simultaneous heart and kidney transplantation increased every year, and the International Society of Heart and Lung Transplantation has reported simultaneous heart and kidney transplantations with survival rates of 76% at 1 year, and 67% at 2 years [10] . Given the good results of simultaneous heart and kidney transplantation reported in the literature, the indications have expanded and contraindications have diminished. However, there are no guidelines at this moment. It is unclear whether patients with heart failure and renal Comparison between Group 1 (heart transplantation in patients with preoperative serum creatinine <2 mg dl À1 , n = 231), Group 2 (isolated heart transplantation in patients with preoperative serum creatinine !2 mg dl À1 , n = 32), and Group 3 (simultaneous heart and kidney transplantation in patients with preoperative serum creatinine !2 mg dl À1 , n = 13).
insufficiency should receive a simultaneous heart and kidney transplant or whether isolated heart transplantation is sufficient to restore native renal function. Medical controversy exists about simultaneous heart and kidney transplantation in that it may not represent a rational use of scarce donor resources: two organs are allocated to a single patient with double-organ failure rather than transplanting two different patients with single organ failure. It is imperative to select the appropriate candidates for simultaneous heart and kidney transplantation otherwise some patients would be 'overtreated'. In this current series, the survival of simultaneous heart and kidney transplantation did not match the survival of the previously reported series [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . There was a significant amount of in-hospital mortality, which was primarily from overwhelming sepsis due to bacterial or fungal infection. The poor results of simultaneous heart and kidney transplantation in this current series were probably a result of the inclusion of three patients with re-transplantation, seven patients with previous cardiac surgery and eight patients in UNOS status IA. In this situation, the ischaemic renal graft is exposed to low perfusion pressure and high doses of vasoconstrictive drugs after transplantation. It may subsequently lead to renal allograft dysfunction, rejection, postoperative dialysis and even mortality [23, 24] .
Although the experience was limited, our results suggested that simultaneous kidney transplantation may not carry any significant survival benefit or freedom from dialysis in patients with preoperative renal dysfunction. The longterm dialysis-free and patient survival in the isolated heart transplant group also compares well with the simultaneous heart and kidney transplant population. Simultaneous heart Comparison between Group 1 (heart transplantation in patients with preoperative serum creatinine <2 mg dl À1 , n = 231), Group 2 (isolated heart transplantation in patients with preoperative serum creatinine !2 mg dl À1 , n = 32), and Group 3 (simultaneous heart and kidney transplantation in patients with preoperative serum creatinine !2 mg dl À1 , n = 13).
and kidney transplantation should be reserved for certain subgroups of heart-failure recipients with preoperative renal dysfunction, such as those patients with no previous cardiac operation and in UNOS status II. A large randomised controlled trial is necessary to determine the optimal strategies to improve the dialysis-free and patient survival in the management of heart transplant patients with preoperative renal dysfunction.
Study limitation
This study was limited by small case number and retrospective study. The selection of isolated heart transplantation or simultaneous heart and kidney transplantation was non-random and uncontrolled, and thus susceptible to bias. Both groups were not comparable because patients undergoing simultaneous heart and kidney transplantation had a high serum creatinine and a high dialysis rate at transplant. Kidneys were transplanted mostly in patients on dialysis with serum creatinine around 7 mg dl
À1
. However, this study is one of the largest series of simultaneous heart and kidney transplantation and the first study to compare the results of isolated heart transplantation and simultaneous heart and kidney transplantation in patients with co-existing end-stage heart and renal failure.
Conclusions
Simultaneous kidney transplantation is an effective therapy for patients depending on dialysis pretransplant, reducing postoperative risk of mortality in these very sick patients to the level of patients with less severe renal disease not requiring dialysis before transplant.
